ClearPoint Neuro Inc (CLPT):企業の財務・戦略的SWOT分析

◆英語タイトル:ClearPoint Neuro Inc (CLPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME206146FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ClearPoint Neuro Inc (ClearPoint) is a medical equipment company. It develops and commercializes platforms for performing invasive surgical procedures. Its products include ClearPoint system a surgical platform, that enables delivery of therapies treat a neurological diseases and disorders by providing real-time MRI guidance; SmartFlow Neuro Ventricular Cannula a MRI-Guided Drug Delivery system and TRANBERG Thermal Therapy System. These systems used for performing invasive surgeries on brain and heart. The company has partnership with various medical device companies and academic institutions for the development and commercialization of its product platforms and core technologies. It serves physicians and hospitals. ClearPoint is headquartered in Irvine, California, the US.

ClearPoint Neuro Inc Key Recent Developments

Apr 06,2021: ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
Mar 24,2021: ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel
Mar 04,2021: ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
Feb 19,2021: ClearPoint Neuro to Announce Fourth Quarter and Full Year 2020 Results on March 4, 2021
Feb 18,2021: ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips

This comprehensive SWOT profile of ClearPoint Neuro Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ClearPoint Neuro Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

ClearPoint Neuro Inc – Key Information
ClearPoint Neuro Inc – Overview
ClearPoint Neuro Inc – Key Employees
ClearPoint Neuro Inc – Key Employee Biographies
ClearPoint Neuro Inc – Key Operational Heads
ClearPoint Neuro Inc – Major Products and Services
ClearPoint Neuro Inc – History
ClearPoint Neuro Inc – Company Statement
ClearPoint Neuro Inc – Locations And Subsidiaries
ClearPoint Neuro Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ClearPoint Neuro Inc – Business Description
ClearPoint Neuro Inc – Corporate Strategy
ClearPoint Neuro Inc – SWOT Analysis
SWOT Analysis – Overview
ClearPoint Neuro Inc – Strengths
ClearPoint Neuro Inc – Weaknesses
ClearPoint Neuro Inc – Opportunities
ClearPoint Neuro Inc – Threats
ClearPoint Neuro Inc – Key Competitors

Section 3 – Company Financial Performance Charts

ClearPoint Neuro Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ClearPoint Neuro Inc, Key Information
ClearPoint Neuro Inc, Key Ratios
ClearPoint Neuro Inc, Share Data
ClearPoint Neuro Inc, Major Products and Services
ClearPoint Neuro Inc, History
ClearPoint Neuro Inc, Key Employees
ClearPoint Neuro Inc, Key Employee Biographies
ClearPoint Neuro Inc, Key Operational Heads
ClearPoint Neuro Inc, Other Locations
ClearPoint Neuro Inc, Subsidiaries
ClearPoint Neuro Inc, Key Competitors
ClearPoint Neuro Inc, SWOT Analysis
ClearPoint Neuro Inc, Ratios based on current share price
ClearPoint Neuro Inc, Annual Ratios
ClearPoint Neuro Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ClearPoint Neuro Inc (CLPT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aceto Corp (ACET):企業の財務・戦略的SWOT分析
    Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • L-3 Unmanned Systems, Inc.:企業の戦略・SWOT・財務分析
    L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary L-3 Unmanned Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Oxtex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxtex Ltd (Oxtex), formerly Oxtexs Ltd is a medical device company that offers novel self inflating tissue expansion and medical devices. The company’s products include implantable self-inflating tissue expanders that are suitable for specific needs of the clinician and the patient. It uses …
  • Esterline Technologies Corporation:戦略・SWOT・企業財務分析
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Delek Group Ltd:戦略・SWOT・企業財務分析
    Delek Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Delek Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chronix Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Chronix Biomedical Inc (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests such as second opinion tests and delta dot tests. Its second opinion tests include supplementary blood …
  • Grupo Nacional Provincial, S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • LMI Aerospace, Inc.:企業の戦略的SWOT分析
    LMI Aerospace, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Lumenis Ltd:企業の戦略的SWOT分析
    Lumenis Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ingram Micro Inc.:企業の戦略・SWOT・財務情報
    Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Micro Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grain Processing Corp:企業の戦略的SWOT分析
    Grain Processing Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • RXi Pharmaceuticals Corp (RXII):製薬・医療:M&Aディール及び事業提携情報
    Summary RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes immuno-oncology therapeutics to treat cancer. The company’s technology sd-rxRNA includes RXI-109 and IncRNA. Its lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of …
  • Warner Media LLC:企業の戦略的SWOT分析
    Warner Media LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Commonwealth Bank of Australia:戦略・SWOT・企業財務分析
    Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report Summary Commonwealth Bank of Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ramba Energy Ltd (R14):石油・ガス:M&Aディール及び事業提携情報
    Summary Ramba Energy Ltd (Ramba Energy), a subsidiary of Redmount Holdings Ltd, is an oil and gas company that offers exploration and production of oil and gas properties in Indonesia. The company provides services such as inbound and outbound transportation activities, seaport and airport cargo han …
  • Warp Drive Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Warp Drive Bio Inc (Warp Drive) is a natural products provider. The company utilizes the proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART platform offers solutions to the pharmaceutical opportunities. Warp Drive's integr …
  • Spindletop Oil & Gas Co (SPND):企業の財務・戦略的SWOT分析
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Seacor Holdings Inc (CKH):企業の財務・戦略的SWOT分析
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation, logistics and risk management consultancy services. The company offers ocean transportation and logistics services; inland transportation and logistics services; Witt O'Brien' …
  • BioClinica Inc:企業の戦略的SWOT分析
    BioClinica Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Apotex, Inc.:企業の戦略・SWOT・財務情報
    Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆